These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7545341)

  • 21. [The value of self-assessment in management of patients with benign prostatic hyperplasia].
    Schneider HJ
    Fortschr Med; 1995 Jun; 113(16):250-2. PubMed ID: 7543430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of transurethral thermotherapy at the Mayo Clinic.
    Blute ML; Larson TR; Hanson KA; King BF
    Mayo Clin Proc; 1998 Jun; 73(6):597-602. PubMed ID: 9621870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms.
    d'Ancona FC; Francisca EA; Debruyne FM; de la Rosette JJ
    J Endourol; 1997 Aug; 11(4):285-9. PubMed ID: 9376850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transurethral laser therapy and urinary tract infections.
    Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
    Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transurethral laser therapy of benign prostatic hyperplasia].
    Conrad S; Gonnermann D; Heinzer H; Kabalin JN; Huland H
    Urologe A; 1995 Jan; 34(1):25-34. PubMed ID: 7533448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of urethral stents (Urospiral 2™) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study.
    Rouprêt M; Misraï V; de Fourmestraux A; Cour F; Richard F; Chartier-Kastler E
    Neurourol Urodyn; 2011 Mar; 30(3):374-9. PubMed ID: 20860015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transurethral laser resection of the prostate.
    Daughtry JD; Rodan BA
    J Clin Laser Med Surg; 1992 Aug; 10(4):269-72. PubMed ID: 10150943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Problems with the intraurethral spiral].
    Böss HP; Pestalozzi D; Knönagel H
    Helv Chir Acta; 1992 Oct; 59(3):489-92. PubMed ID: 1281464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities?
    de la Rosette J; Alivizatos G
    Eur Urol; 2006 Sep; 50(3):418-20. PubMed ID: 16687204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transurethral balloon laser thermotherapy for symptomatic benign prostatic hyperplasia: preliminary clinical results.
    Furuya S; Tsukamoto T; Kumamoto Y; Daikuzono N; Liong ML
    J Endourol; 1995 Apr; 9(2):145-9. PubMed ID: 7543325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up.
    Seitz M; Sroka R; Gratzke C; Schlenker B; Steinbrecher V; Khoder W; Tilki D; Bachmann A; Stief C; Reich O
    Eur Urol; 2007 Dec; 52(6):1717-22. PubMed ID: 17628326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A self-retaining intraurethral device as an alternative to indwelling catheter and prostatectomy].
    Nissenkorn I; Aronheim M; Sluzker D; Richter S
    Harefuah; 1990 Nov; 119(9):254-6. PubMed ID: 1701751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.